# reload+after+2024-01-22 15:26:16.462701
address1§5 Park Plaza
address2§Suite 1750
city§Irvine
state§CA
zip§92614
country§United States
phone§(949) 354-6499
website§https://www.aeonbiopharma.com
industry§Biotechnology
industryKey§biotechnology
industryDisp§Biotechnology
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
fullTimeEmployees§8
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Marc  Forth', 'age': 52, 'title': 'President, CEO & Director', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 1128975, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Chad K. Oh M.D.', 'age': 65, 'title': 'Chief Medical Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 587400, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Peter A. Reynolds CPA', 'age': 65, 'title': 'Chief Financial Officer', 'yearBorn': 1958, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alex  Wilson', 'age': 37, 'title': 'Executive VP, Chief Legal Officer & Corporate Secretary', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.094
currency§USD
dateShortInterest§1702598400
forwardEps§-1.54
exchange§ASE
quoteType§EQUITY
shortName§AEON Biopharma, Inc.
longName§AEON Biopharma, Inc.
firstTradeDateEpochUtc§1690205400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§818fa4c7-1301-356c-8781-c235768c4fd3
messageBoardId§finmb_247856902
gmtOffSetMilliseconds§-18000000
targetHighPrice§18.0
targetLowPrice§18.0
targetMeanPrice§18.0
targetMedianPrice§18.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§1.141
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
